Botulinum Toxin Dosing Trends in Spasmodic Dysphonia Over a 20-year Period

Summary Objectives The study aims to (1) identify the botulinum toxin (BTX) dosing trend in a cohort of patients who received at least 20 injections for the treatment of adductor spasmodic dysphonia (ADSD), (2) describe two distinct BTX dosing trends in treating ADSD (a “classic” dosing trend that i...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of voice 2017-01, Vol.31 (1), p.107-110
Hauptverfasser:	Namin, Arya W, Christopher, Kara M, Eisenbeis, John F
Format:	Artikel
Sprache:	eng
Schlagworte:	Acetylcholine Release Inhibitors - administration & dosage Acetylcholine Release Inhibitors - adverse effects Adult Aged Botulinum toxin Botulinum Toxins, Type A - administration & dosage Botulinum Toxins, Type A - adverse effects Dosing intervals Drug Administration Schedule Drug effects Dysphonia Dysphonia - diagnosis Dysphonia - drug therapy Dysphonia - physiopathology Female Humans Initial dose Injections Laryngeal Muscles - drug effects Laryngeal Muscles - innervation Male Middle Aged Missouri Otolaryngology Patients Practice Patterns, Physicians' - trends Retrospective Studies Spasmodic dysphonia Time Factors Treatment Outcome Trend Voice - drug effects
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!